Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Irene Adán‐Barrientos"'
Autor:
Rodrigo Lázaro‐Gorines, Patricia Pérez, Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Guillermo Albericio, David Astorgano, Sara Flores, Joanna Luczkowiak, Nuria Labiod, Seandean L. Harwood, Alejandro Segura‐Tudela, Laura Rubio‐Pérez, Yudhi Nugraha, Xiaoran Shang, Yuxing Li, Carlos Alfonso, Kaylin A. Adipietro, Dinendra L. Abeyawardhane, Rocío Navarro, Marta Compte, Wenbo Yu, Alexander D. MacKerell Jr, Laura Sanz, David J. Weber, Francisco J. Blanco, Mariano Esteban, Edwin Pozharski, Raquel Godoy‐Ruiz, Inés G. Muñoz, Rafael Delgado, David Sancho, Juan García‐Arriaza, Luis Álvarez‐Vallina
Publikováno v:
Advanced Science, Vol 10, Iss 34, Pp n/a-n/a (2023)
Abstract Administration of neutralizing antibodies (nAbs) has proved to be effective by providing immediate protection against SARS‐CoV‐2. However, dual strategies combining virus neutralization and immune response stimulation to enhance specific
Externí odkaz:
https://doaj.org/article/83ee823ecfc342e88a1c1efafa321622
Autor:
Javier Arranz-Nicolás, Antonia Ávila-Flores, Rosa Liébana, Judith Leitner, Peter Steinberger, María del Carmen Moreno-Ortiz, Isabel Mérida, Miguel Martin-Salgado, Irene Adán-Barrientos
Publikováno v:
Cancer immunology, immunotherapy : CII. 70(11)
Antibody-based therapies blocking the programmed cell death-1/ligand-1 (PD-1/PD-L1) axis have provided unprecedent clinical success in cancer treatment. Acquired resistance, however, frequently occurs, commonly associated with the upregulation of add
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::949fbe7da887daf15c38872b919af67e
https://pubmed.ncbi.nlm.nih.gov/33837851
https://pubmed.ncbi.nlm.nih.gov/33837851